Swedish Orphan Biovitrum AB (publ) (BIT:1SOBI)
26.40
0.00 (0.00%)
At close: Mar 28, 2025
BIT:1SOBI Revenue
In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B SEK with 17.65% growth. Swedish Orphan Biovitrum AB had revenue of 7.44B in the quarter ending December 31, 2024, with 8.67% growth.
Revenue
26.03B SEK
Revenue Growth
+17.65%
P/S Ratio
n/a
Revenue / Employee
14.15M SEK
Employees
1,840
Market Cap
9.08B EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Intesa Sanpaolo | 25.83B |
UniCredit | 23.99B |
Enel SpA | 78.95B |
Ferrari | 6.68B |
Assicurazioni Generali | 62.82B |
Eni S.p.A. | 91.21B |
Stellantis | 156.88B |
Leonardo S.p.a. | 17.76B |